UAE Approves New Drug for High Cholesterol Treatment

The UAE has approved the use of a new twice-yearly therapy, Lipfendra, to treat high cholesterol, a condition often described as a 'silent killer.'

This approval makes the UAE the second country globally to adopt the drug, which aims to provide a more convenient and effective management option for patients.

Cardiologists view the therapy as a potential game-changer, as it significantly reduces LDL cholesterol levels and offers a long-term solution for those at risk of heart disease.